Clinical trial

Comparison Between Radiofrequency Ablation and Hypofractionated Proton Beam…

NCT01963429 · National Cancer Center, Korea, Other · Completed

Key facts

NCT number NCT01963429
Title Comparison Between Radiofrequency Ablation and Hypofractionated Proton Beam Radiation for Recurrent/Residual HCC
Official title A Randomized Phase III Study of the Comparison Between Radiofrequency Ablation and Hypofractionated Proton Beam Radiation in Patients With Recurrent/Residual Small Hepatocellular Carcinoma (APROH Study)
Lead sponsor National Cancer Center, Korea, Other
Status Completed
Study type Interventional
Conditions Recurrent Small Hepatocellular Carcinoma, Residual Small Hepatocellular Carcinoma
Intervention type Procedure, Radiation
Interventions radiofrequency ablation, Proton beam therapy
Enrollment 144
Start date Sep 30, 2013
Primary completion Jan 20, 2020
Completion Jan 20, 2020
First posted Oct 16, 2013
Last update posted Oct 6, 2020
Countries South Korea

At a glance

  • 1–9 Study sites
  • No Results posted
  • 1–9 Linked FDA submissions

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About ClinicalTrials.gov studies

ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.

Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date:

Browse all ClinicalTrials.gov studies